Literature DB >> 10717311

Adventures with poxviruses of vertebrates.

F Fenner1.   

Abstract

Because they were the largest of all viruses and could be visualised with a light microscope, the poxviruses were the first viruses to be intensively studied in the laboratory. It was clear from an early date that they caused important diseases of humans and their domestic animals, such as smallpox, cowpox, camelpox, sheeppox, fowlpox and goatpox. This essay recounts some of the early history of their recognition and classification and then expands on aspects of research on poxviruses in which the author has been involved. Studies on the best-known genus, Orthopoxvirus, relate to the use of infectious ectromelia of mice as a model for smallpox, embracing both experimental epidemiology and pathogenesis, studies on the genetics of vaccinia virus and the problem of non-genetic reactivation (previously termed 'transformation') and the campaign for the global eradication of smallpox. The other group of poxviruses described here, the genus Leporipoxvirus, came to prominence when the myxoma virus was used for the biological control of Australian wild rabbits. This provided a unique natural experiment on the coevolution of a virus and its host. Future research will include further studies of the many immunomodulatory genes found in all poxviruses of vertebrates, since these provide clues about the workings of the immune system and how viruses have evolved to evade it. Some of the many recombinant poxvirus constructs currently being studied may come into use as vaccines or for immunocontraception. A field that warrants study but will probably remain neglected is the natural history of skunkpox, raccoonpox, taterapox, yabapox, tanapox and other little-known poxviruses. A dismal prospect is the possible use of smallpox virus for bioterrorism.

Entities:  

Mesh:

Year:  2000        PMID: 10717311     DOI: 10.1016/S0168-6445(00)00027-9

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  35 in total

Review 1.  Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.

Authors:  Masmudur M Rahman; Gerard J Madlambayan; Christopher R Cogle; Grant McFadden
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-07       Impact factor: 7.638

2.  Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.

Authors:  Helen E Farrell; Nick Davis-Poynter; Kimberley Bruce; Clara Lawler; Lars Dolken; Michael Mach; Philip G Stevenson
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

3.  Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.

Authors:  Rosalinda A Doty; Jia Liu; Grant McFadden; Edward J Roy; Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2013-01

4.  Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.

Authors:  Sonia Tusell Wennier; Jia Liu; Shoudong Li; Masmudur M Rahman; Mahmoud Mona; Grant McFadden
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

5.  Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

Authors:  Marianne M Stanford; Mae Shaban; John W Barrett; Steven J Werden; Philippe-Alexandre Gilbert; Joe Bondy-Denomy; Lisa Mackenzie; Kevin C Graham; Ann F Chambers; Grant McFadden
Journal:  Mol Ther       Date:  2007-11-13       Impact factor: 11.454

6.  Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.

Authors:  Darnell T Josiah; Dongqin Zhu; Fernanda Dreher; John Olson; Grant McFadden; Hannah Caldas
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

7.  A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication.

Authors:  Wondimagegnehu M Teferi; Kristopher Dodd; Rob Maranchuk; Nicole Favis; David H Evans
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Methodology for the efficient generation of fluorescently tagged vaccinia virus proteins.

Authors:  N Bishara Marzook; Dean J Procter; Helena Lynn; Yui Yamamoto; Jacquelyn Horsington; Timothy P Newsome
Journal:  J Vis Exp       Date:  2014-01-17       Impact factor: 1.355

9.  A survey of host range genes in poxvirus genomes.

Authors:  Kirsten A Bratke; Aoife McLysaght; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2012-12-23       Impact factor: 3.342

Review 10.  The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway.

Authors:  Nicholas J Buchkovich; Yongjun Yu; Carisa A Zampieri; James C Alwine
Journal:  Nat Rev Microbiol       Date:  2008-03-03       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.